AMRN Q4 2021 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$144M-13.6% YoY

Gross Profit

$114M78.8% margin

Operating Income

$16M11.2% margin

Net Income

$15M10.2% margin

EPS (Diluted)

$0.80

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$401M

Stockholders' Equity

$667M

Cash & Equivalents

$219M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$144M	$167M	-13.6%
Gross Profit	$114M	$132M	-14.1%
Operating Income	$16M	$7M	+125.4%
Net Income	$15M	$5M	+198.4%

Revenue Segments

Product

$144M99%

Licensing And Royalty

$769,0001%